Skip to main content
. 2022 Apr 18;37(16):e128. doi: 10.3346/jkms.2022.37.e128

Table 1. Frequencies of adverse drug reactions to first-line anti-tuberculosis drugs.

Adverse drug reactions INH RIF ETB PZA Total
Nausea 633 (24.2) 743 (28.5) 625 (23.9) 610 (23.4) 2,611
Hepatic enzyme abnormalitya 670 (26.5) 649 (25.6) 544 (21.5) 668 (26.4) 2,531
Rashb 484 (23.2) 605 (29.0) 519 (24.8) 481 (23.0) 2,089
Pruritis 418 (25.9) 493 (30.5) 358 (22.1) 348 (21.5) 1,617
Vomiting 387 (24.4) 469 (30.0) 358 (22.6) 373 (23.5) 1,587
Urticaria 165 (22.3) 241 (32.6) 189 (25.5) 145 (19.6) 740
Anorexia 166 (24.0) 191 (27.6) 176 (25.4) 159 (23.0) 692
Dyspepsia 164 (26.3) 182 (29.2) 144 (23.1) 133 (21.3) 623
Dizziness 144 (24.5) 168 (28.6) 149 (25.4) 126 (21.5) 587
Arthralgia 112 (20.3) 117 (21.2) 107 (19.3) 217 (39.2) 553
Diarrhea 103 (21.7) 180 (37.9) 106 (22.3) 86 (18.1) 475
Headache 112 (24.5) 126 (27.5) 120 (26.2) 100 (21.8) 458
Fever 82 (21.1) 137 (35.3) 100 (25.8) 69 (17.8) 388
Hyperuricemia 13 (3.8) 15 (4.4) 54 (15.7) 261 (76.1) 343
Myalgia 47 (21.0) 67 (29.9) 47 (21.0) 63 (28.1) 224
Abdominal pain 50 (23.5) 64 (30.0) 52 (24.4) 47 (22.1) 213
Malaise 40 (24.8) 50 (31.1) 37 (23.0) 34 (21.1) 161
Eosinophilia 34 (25.0) 45 (33.1) 32 (23.5) 25 (18.4) 136
Fatigue 35 (28.0) 37 (29.6) 30 (24.0) 23 (18.4) 125
Leucopenia 29 (28.2) 43 (41.7) 21 (20.4) 10 (9.7) 103
Dyspnea 21 (22.6) 35 (37.6) 21 (22.6) 16 (17.2) 93
Thrombocytopenia 18 (22.0) 37 (45.1) 15 (18.3) 12 (14.6) 82
Vision abnormality 11 (14.1) 15 (19.2) 42 (53.8) 10 (12.8) 78
Tremor 22 (29.3) 24 (32.0) 16 (21.3) 13 (17.3) 75
Cachexia 20 (28.2) 16 (22.5) 20 (28.2) 15 (21.1) 71
Constipation 20 (31.7) 18 (28.6) 14 (22.2) 11 (17.5) 63
Weight decrease 13 (24.1) 16 (29.6) 15 (27.8) 10 (18.5) 54

Data are shown as numbers (row %).

INH = isoniazid, RIF = rifampicin, ETB = ethambutol, PZA = pyrazinamide.

aHepatic enzyme abnormality includes hepatic enzyme increased, hepatic function abnormal, SGOT increased, SGPT increased ‘jaundice, hepatitis, gamma-GT increased, bilirubinemia, hepatocellular damage, and cholecystitis’; bRash includes ‘rash, rash maculopapular and rash erythematous’.